Shengnan Liu

5.3k citations
180 papers · 3.9k indexed · 1 hit paper · h-index 31
Topics
Cancer-related molecular mechanisms research (10 papers)RNA modifications and cancer (9 papers)MicroRNA in disease regulation (9 papers)

In The Last Decade

Shengnan Liu

173 papers receiving 3.8k citations

Hit Papers

Signal amplification in the KEAP1-NRF2-ARE antioxidant re...2022202620232024202250100150200250

Peers

Shengnan Liu
Comparison fields: 5 of 170
  • Molecular Biology 1.5k
  • Cancer Research 506
  • Plant Science 482
  • Materials Chemistry 431
  • Biomedical Engineering 413
Replace Jing Wen with:
Jing Wen China
Wen Liu China
Yanli Liu China
Zhenzhen Li China
Lina Ghibelli Italy
Yanli Li China
Jaleh Barar Iran
Yanxin Li China
Cheng Jin China
Jiali Liu China
Shengnan Liu relative to Jing Wen China Jing Wen's profile →
Citations per field
00.5×1.5×2.3×
Jing Wen · 1×
Citations per year

Countries citing papers authored by Shengnan Liu

Since Specialization
Citations

This map shows the geographic impact of Shengnan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Liu more than expected).

Fields of papers citing papers by Shengnan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Liu. The network helps show where Shengnan Liu may publish in the future.

Co-authorship network of co-authors of Shengnan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Liu. A scholar is included among the top collaborators of Shengnan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Liu. Shengnan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 3
3 2
4 3
5 3
6 2
7 11
8 5
9 5
10 8
11 7
12 3
13 5
14 9
15 8
16 7
17 6
18 17
19 101
20 187

About Shengnan Liu

Shengnan Liu is a scholar working on Cancer Research, Biological Psychiatry and Molecular Biology, having authored 180 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Cancer Research (506 citations), Biological Psychiatry (72 citations) and Molecular Biology (1.5k citations). Shengnan Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jingbo Pi, Qiang Zhang, Qisen Xiang, Yunfang Ma, Yanhong Bai, Xinrong Zhang, Chengxiao Zhang, Hongni Wang, Lihua Shen and Sichun Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026